Product Description
The global patent foramen ovale closure device market was valued at $497.9 million in 2025. This is expected to increase over the forecast period at a 5.5% CAGR, reaching $724.7 million by 2032.
The full report suite on the global market for patent foramen ovale (PFO) closure devices includes devices that treat PFO, a defect in the septum between the two atrial chambers of the heart.
The report includes data for 65+ countries across 7 different regions, which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Foramen Ovale Closure Device Market Trends

Patent foramen ovale (PFO) is relatively common in the general population; however, the majority of cases remain asymptomatic and do not require intervention. As a result, only a small subset of patients, primarily those with a history of cryptogenic stroke or other embolic events, are considered candidates for patent foramen ovale closure. This narrow treatment population limits overall unit volumes and constrains the pace of market expansion, while also reducing incentives for new entrants to invest heavily in device development.
Global Foramen Ovale Closure Device Market Share Insights

- Abbott was the leading competitor in the global patent foramen ovale closure device market. The company offers Amplatzer™ PFO Occluder. The fact that they have one of the early devices available in the market allows them to maintain their standing as the leader of the market.
- Gore was the second-leading competitor in the global patent foramen ovale closure device market in 2025. The company offers its Gore® Cardioform Septal Occluder. The Gore® Cardioform Septal Occluder is approved for atrial septal defect (ASD) and PFO closure in Europe; however, regional companies limit the company’s expansion globally.
Global Foramen Ovale Closure Device Market Segmentation Summary
- Patent Foramen Ovale Closure Device Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis for Top Competitors, Mergers & Acquisitions, Emerging Markets & Technologies, Key Analysis Updates. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.